COVID-19 Vaccination in Patients with Pre-Solid-Organ Transplantation
Journal Title: Journal of Clinical Immunology & Microbiology - Year 2021, Vol 2, Issue 2
Abstract
Vaccine such as influenza vaccine, is administered in stable transplant recipients, although live attenuated virus vaccines are contraindicated, generally due to risk of disseminated infection [1,2]. Neither efficacy, safety, nor durability are well known in transplant recipients due to exclusion of them from recent COVID-19 vaccine trials [1,2]. Currently, there are no SARSCoV-2 vaccine platforms using attenuated live virus approved in phase III trials. Nevertheless, if they are approved for use, concerns, including potential decrease in efficacy in immunocompromised patients, potential for vaccine-related allograft rejection, unknown durability of the immune response, and long-term safety data still exist. Due to experience with neither the influenza vaccine nor the adjuvant recombinant zoster vaccine having been related to allograft rejection, successful administration of influenza and adjuvanted recombinant zoster vaccines to stable transplant recipients, and unanticipated vaccine-related adverse events to the allograft having not borne out, the influenza and adjuvanted recombinant zoster vaccines are able to be extrapolated to COVID-19 vaccines [2,3]. In immunocompromised host, concerns for adenoviral vector vaccines are focused on a viral infection, but these concerns have no scientific evidence. Although newly approved adenoviral-vector use for vaccination, this vaccine platform has been used for decades for gene therapy for cancer and other rare diseases. Inactivated virus and protein subunit vaccine platforms that have been used in transplant recipients for other infections, such as human papilloma virus, pertussis, and hepatitis A and B, are currently under investigation for SARS-CoV-2 (COVID-19) infection in transplant recipients [2].
Authors and Affiliations
Attapon Cheepsattayakorn*, Ruangrong Cheepsattayakorn, Porntep Siriwanarangsun
Keywords
Related Articles
- EP ID EP699099
- DOI http://dx.doi.org/10.46889/JCIM.2021.2202
- Views 75
- Downloads 0
Deforestation, Air Pollution and Brazilian COVID-19 Variant
Aim of this work is to submit to the researcher the relationship whit climate condition, air pollution and deforestation in Manaus zone in Brazil and the rapid spread of so called Brazilian COVID-19 variant. Also othe...
Eating Food that Flushes the Lymph System is Essential for Preventing Cancer, Alzheimer and Autoimmune Diseases
In my article, I underlined that to be healthy we need to periodically: 1) Flush the lymph system (which fills the space between the cells) with a combination of turmeric, ginger and garlic; and 2) Flush also the parasit...
Immuno-Multi-Therapy and Prophylaxis Efficacy against COVID-19
In the context of the current COVID-19 pandemic, strategies for finding effective therapies advocate the so-called "therapeutic repositioning" approach, i.e., the use of existing molecules on the pharmaceutical market,...
Explaining the Cancer Cure with Frequencies
I spent 40 years of my life investigating the human aura. First, I started photographic it - it can be photographed in high frequency electric field and it is called Kirlian photography. I found that positive emotions...
A Rapidly Progressive Case of Skin and Soft Tissues Necrosis in a COVID-19 Positive Patient
Sars-Cov2 infection can result in numerous and varied skin manifestations including vasculopathy, bullous lesions and rarely necrotic lesions. At present, the aetiopathogenetic mechanism is still unclear. We report a cas...